Physicochemical properties of brand and generic infusion fluid preparations (Part 3): Investigation of type 1 hypotonic infusion fluids

Author:

Takei Sawako1,Katsuyama Soh2,Hori Yusuke1

Affiliation:

1. Center for Experimental Pharmacy Practice, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

2. Clinical Pharmaceutical Sciences Course, Department of Pharmaceutical Sciences, Nihon Pharmaceutical University, Kitaadachi-gun, Saitama Prefecture, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Reference31 articles.

1. 1. Ministry of Health, Labor and Welfare. Basic policy on economic and fiscal management and reform 2017. https://www5.cao.go.jp/keizai-shimon/kaigi/cabinet/2017/decision0609.html (accessed October 8, 2021). (in Japanese)

2. 2. Ministry of Health, Labor and Welfare. 4. Percentage of generic drugs used by each insurer, (as of March 2021). https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000190726.html (accessed October 8, 2021). (in Japanese)

3. 3. Medical Division, Insurance Bureau, Ministry of Health, Labor and Welfare. About the 2016 drug price system reform. https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000114391.pdf (accessed October 8, 2021). (in Japanese)

4. 4. Ministry of Health, Labor and Welfare. List of items listed in NHI price standards and information on generic drugs (until March 31, 2nd year of Reiwa) 2 injections. https://www.mhlw.go.jp/topics/2019/08/tp20190819-01.html (accessed October 8, 2021). (in Japanese)

5. 5. Ministry of Health, Labor and Welfare. List of items listed in NHI price standards and information on generic drugs (until March 31, 2nd year of Reiwa). List of basic drugs, etc. for which modified dispensing is permitted as with generic drugs. https://www.mhlw.go.jp/topics/2019/08/tp20190819-01.html (accessed October 8, 2021). (in Japanese)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3